ITERcare - the easiest way to schedule your healthcare
ITERcare Lda
Share capital
MedTech
Portugal
ITERcare - the easiest way to schedule your healthcare
ITERcare Lda
Share capital
MedTech
Portugal
Increased
€25 000.00
19.2% financed
€130 000.00
My target
€200 000.00
Maximum target
4.00%
Share capital
€ 4 775 000.00
Pre-money valuation
€100.00
Stock price
0
Shareholders
€130 000.00
My target
€200 000.00
Maximum target
4.00%
Share capital
€ 4 775 000.00
Pre-money valuation
€100.00
Stock price
0
Shareholders

Join ITERcare, a leader in digital healthcare innovation. With their successful track record in Portugal, including over 400,000 client accounts and €6 million in transactions, they're now set to expand their reach globally. This investment opportunity invites you to play a crucial role in reshaping healthcare through technology.

Campaign Details

  • Minimum Investment: 100 EUR
  • Investment Process: Organized through a Special Purpose Vehicle (SPV) for efficient and transparent fund management.
  • Company name: ITERcare lda (Portugal)
  • Reg. Nr.: 517337720, date of registration: 05.05.2023

Why Invest in ITERcare?

  • Massive Market Opportunity: Targeting a segment of the €600 billion global healthcare market (Source: McKinsey).
  • Innovative Technology: Harnessing AI, telemedicine, and blockchain to redefine healthcare experiences.
  • Substantial Growth: Remarkable achievement of 1,000,000 bookings and €6M transacted in just 15 months in Portugal.
  • Expansion Plans: Prepared for entry into new markets, including Brazil, with extensive market research and potential for high growth.
  • Customer acquisition: A dual-model approach combining free consumer access and a provider subscription model.

Company description

ITERcare is revolutionizing healthcare access with its digital platform, designed to simplify how patients connect with healthcare providers. Focusing on user-friendly solutions, ITERcare tackles common healthcare challenges like complex systems, difficult access, and data security concerns. With over 400,000 registered users, ITERcare is making healthcare more accessible and reducing the traditional costs and complexities involved. For patients, using ITERcare to book appointments and consult with healthcare professionals is completely free of charge, ensuring healthcare is accessible to everyone.

ITERcare offers a straightforward electronic booking system that connects patients with medical specialists easily. The platform enables patients to schedule appointments and access video consultations, allowing for remote and convenient medical advice. With more than 1,000,000 bookings and teleconferences facilitated, ITERcare is a leading solution in digital healthcare, providing efficient and accessible services. Its commitment to free access for patients underscores ITERcare’s dedication to improving healthcare experiences and accessibility.

Company Benefits:

  • Centralized User-Friendly Digital Service: ITERcare provides a centralized, user-friendly digital platform that streamlines communication between patients and healthcare providers, reduces costs, and enhances patient satisfaction.
  • Innovative Technologies: The company integrates cutting-edge technologies like VR, AI, blockchain, and NLP to create a comprehensive and patient-focused healthcare ecosystem.
  • Reduced Healthcare Costs: By simplifying the healthcare process, ITERcare helps in reducing the traditional costs associated with healthcare services.
  • Automated System Integration: ITERcare offers automatic validation in the National Health Service (SNS) and automatic SINAVE notifications, showcasing its advanced capability in integrating with healthcare regulatory systems to ensure compliance and efficiency.

Problems Solved by the Company:

  • Complex Health System: ITERcare addresses issues like unsecure information management and inefficient care coordination, which are common challenges in the healthcare sector.
  • Accessibility and Data Security: The platform offers easy and quick access to healthcare services while ensuring data security and protection.
  • Fragmented Healthcare System: ITERcare tackles the problem of a fragmented healthcare system by centralizing services and making them more accessible to both patients and healthcare providers.

Current Relevance:

  • Rapid Technological Changes: The healthcare industry is undergoing significant digital transformations, accelerated by global challenges like COVID-19.
  • Rising Demand for Digital Healthcare Solutions: There is a growing need for efficient and accessible digital healthcare services worldwide, which ITERcare aims to fulfill.

Company Achievements:

  • Substantial User Base: ITERcare has successfully connected over 400,000 clients in Portugal alone, demonstrating the platform's effectiveness and appeal.
  • Significant Transactions: The company has facilitated transactions worth €6 million, showcasing its financial viability and market acceptance.
  • Milestone Bookings: With over 1,000,000 bookings and teleconferences facilitated, ITERcare stands as a leader in digital healthcare solutions.

Product description

ITERcare offers a straightforward electronic booking system that connects patients with medical specialists easily. The platform enables patients to schedule appointments and access video consultations, allowing for remote and convenient medical advice. With more than 1,000,000 bookings and teleconferences facilitated, ITERcare is a leading solution in digital healthcare, providing efficient and accessible services. Its commitment to free access for patients underscores ITERcare’s dedication to improving healthcare experiences and accessibility.

Product and Services

  • Service Offering: A centralized digital healthcare platform that simplifies patient-provider communication and enhances care delivery.
  • Partner Advantages: Becoming an ITERcare partner elevates partners' businesses to the next level. Health professionals, laboratories, clinics, and pharmacies benefit from a community of users and patients, streamlined access to services, and the ability to provide personalized and effective care around the clock.
  • Cutting-edge Technologies: Embracing VR, AI, blockchain, and NLP to offer a unique healthcare ecosystem that is both comprehensive and patient-focused.

Competitive Edge:

  • Distinct from traditional healthcare services with a focus on telemedicine and a marketplace model.
  • Addresses the critical need for a centralized, easy-to-use healthcare solution.

Operational Model:

  • Standard Subscription: Designed to satisfy the everyday needs of most customers.
  • Custom Subscription: Tailored for specific partnerships, events, and unique requests.
  • Advertising and Marketing: Opportunities to reach potential customers.
  • Data Revenue: Potential revenue streams from anonymized patient data and service information.

Achievements:

  • Over 1,000,000 bookings and teleconferences facilitated since the product launch.
  • A user base of over 400,000 clients and transactions worth €6 million.

Market Trends and Insights

  • Global Healthcare Market Dynamics: The healthcare industry is undergoing a dynamic transformation, especially with the rise of digital solutions. The current global healthcare market is estimated to be around 600 billion dollars, presenting a vast landscape for innovation and growth.
  • ITERcare's Market Focus: ITERcare is targeting a significant portion of this market, focusing on areas that are ripe for digital intervention and improvement. By addressing the specific needs of both healthcare providers and patients, ITERcare is positioned to capture a meaningful share of this expansive market.
  • Leveraging Technology: In line with major industry disruptors, ITERcare is set to transform the healthcare industry without owning the traditional infrastructure of healthcare facilities. This approach mirrors the successful strategies of companies like Facebook, Alibaba, and Airbnb in their respective sectors.
  • Strategic Expansion: Building on its success in Portugal, where it has already established a strong user base and facilitated numerous bookings, ITERcare is strategically expanding to meet the global demand for innovative digital healthcare solutions. The company is leveraging its proven model to address the growing need for efficient and accessible healthcare services worldwide.
  • Business Growth and Operational Efficiency: ITERcare is committed to assisting companies in streamlining Occupational Medicine management and scheduling, helping to make life easier for healthcare providers and their employees, thereby promoting business growth and operational efficiency.

Use of Funds

Investments in ITERcare will be strategically distributed with 21% allocated to CAPEX & Delivery Team, 23% to Marketing and Sales, 18% to Personnel, and the largest portion, 38%, dedicated to Product Development. These allocations are aimed at enhancing market expansion, sales acceleration, team enhancement, and operational advancements, driving ITERcare's growth in digital healthcare.

Financials:

 

  • Projected Revenue: Anticipated to grow significantly, from €0.67 million in 2023, to €20 million in 2024, and €36 million in 2025.
  • Provider Plans Revenue: The revenue for the START, BOOST, and CUSTOM Plan Providers is projected to grow substantially. In 2023, revenues are expected to be €3.229 million, €2.934 million, and €0.545 million respectively, increasing to €401.166 million, €364.7886 million, and €9.325 million by 2027.
  • EBITDA Growth: Aiming for €1.52 million by 2025, indicating strong profitability.
  • Customer Growth Trajectory: Over 500,000 client accounts are anticipated by the end of 2023, demonstrating rapid user base expansion.

Projected Revenue growth (in mill. EUR):

Invest in ITERcare and contribute to a global healthcare revolution. Your participation is a step towards a future where technology enhances healthcare accessibility and efficiency.

We will be happy to answer your questions about ITERcare investment campaign.

Send your questions to [email protected]


Team
Alexandre Rebelo-Marques
Founder & CEO
Rui Hortelão
Co-Founder & COO
Bruna Neves
Marketing Manager
Miguel Rocha
CTO
Alexandre Rebelo-Marques
Founder & CEO

Alexandre Rebelo-Marques, a medical doctor with an MSc, MBA, and BCMAS, has over a decade of experience in health and management, he has been instrumental in revolutionizing the digital healthcare landscape. Under his leadership, ITERcare has successfully connected over 400,000 clients in Portugal alone, transacting €6 million and achieving groundbreaking milestones in integrating AI, telemedicine, and blockchain into healthcare.

Rui Hortelão
Co-Founder & COO

Rui Hortelão, co-founder and Chief Operations Officer of ITERcare, brings a wealth of experience with over 24 years in communications, including roles as a journalist, media manager, senior advisor, and Head of Corporate Affairs, Marketing & Communications at KPMG. His extensive background in entrepreneurship and social responsibility, spanning 14 years, has been integral to shaping ITERcare’s communication strategies, business development and stakeholders management. At ITERcare, Rui has played a pivotal role in developing partnerships and strategic initiatives that effectively convey the company's mission and values.

Bruna Neves
Marketing Manager

Bruna Neves, a graduate in Communication Sciences, specializes in Digital Marketing. With experience in digital marketing, event production, public relations, and project management, she joined ITERcare in August 2022. Her skills include public relations, social media marketing, brand marketing, and CRM.

Miguel Rocha
CTO

With more than 20 years of experience in biomedical data science, systems biology, bioinformatics and artificial intelligence, he is an Associate Professor with Aggregation in the Department of Computer Science at the University of Minho, Director of the Master's Degree in Bioinformatics, senior researcher at the Center for Biological Engineering and Chairman of the Board of Directors of the BioData.pt association. He founded SilicoLife in 2012, a biotechnology company that uses AI and biology to create innovative solutions to the global challenges of the food supplement sector.


Documents (h2 - can be used multiple times accross one text)
Please note, that only registered and Verified investors could access the restricted Project campaign documents.
Apraksts par dokumenta failu Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut
Apraksts par dokumenta failu ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
Apraksts par dokumenta failu Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut
Apraksts par dokumenta failu Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut
To access full project information, please log in or verify your account.
Don't have an account? Register now

Be the first to know about new investment opportunities

Personal data will be processed in accordance with CrowdedHero’s Privacy Policy. You can unsubscribe at any time.